XML 39 R28.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Shareholders' Equity and Share-based Compensation (Tables)
9 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Restricted Stock Units Activity
Time-based Restricted Stock Units (TRSU)
The following table summarizes the Company's TRSU activities for the nine months ended March 31, 2024:
 Number of Restricted Stock
Units
Weighted Average
Grant Date Fair
Value Per Share
Weighted Average
Remaining
Contractual
Term (Years)
Aggregate Intrinsic Value
Nonvested at June 30, 20231,385,065 $32.48 1.73$45,430,132 
Granted641,493 $22.96 
Vested(475,023)$30.31 
Forfeited(32,876)$32.35 
Nonvested at March 31, 20241,518,659 $29.14 1.85$33,471,244 
The following table summarizes the Company’s PRSUs activities for the nine months ended March 31, 2024:

 Number of Performance-based Restricted Stock
Units
Weighted Average
Grant Date Fair
Value Per Share
Weighted Average
Remaining
Contractual Term
(Years)
Aggregate Intrinsic Value
Nonvested at June 30, 2023526,714 $32.19 1.78$17,276,219 
Granted209,250 $21.55 
Vested(123,632)$30.50 
Forfeited(258,957)$26.41 
Nonvested at March 31, 2024353,375 $30.71 1.98$7,788,385 
Summary of Stock Option Activities The following table summarizes the Company's stock option activities for the nine months ended March 31, 2024:
Weighted
WeightedAverage
AverageRemaining
Number ofExercise PriceContractual Aggregate
SharesPer ShareTerm (in years)Intrinsic Value
Outstanding at June 30, 2023319,375 $7.53 0.72$8,071,631 
Exercised(299,375)$7.44 $5,406,850 
Outstanding at March 31, 202420,000 $8.86 0.30$263,600 
Options vested and expected to vest20,000 $8.86 0.30$263,600 
Exercisable at March 31, 202420,000 $8.86 0.30$263,600 
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions
The assumptions used to estimate the fair values of common shares issued under the ESPP were as follows:
Nine Months Ended March 31,
2024
Volatility rate64.0%
Risk-free interest rate5.2%
Expected term1.3 years
Dividend yield0%
Share-based Compensation, Allocation of Recognized Period Costs
Share-based Compensation Expense
The total share-based compensation expense recognized in the Condensed Consolidated Statements of Income for the periods presented was as follows:
Three Months Ended March 31,Nine Months Ended March 31,
2024202320242023
(in thousands)(in thousands)
Cost of goods sold$1,424 $1,723 $3,140 $5,259 
Research and development2,163 2,987 4,586 8,808 
Selling, general and administrative4,878 5,722 10,348 20,052 
$8,465 $10,432 $18,074 $34,119